| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.872 | 45.116 | 54.023 | 67.444 | 72.937 | 81.058 | 98.405 | 96.802 | 109.017 | 105.621 |
| Total Income - EUR | 22.872 | 45.117 | 54.236 | 67.448 | 72.937 | 81.063 | 98.417 | 96.802 | 109.029 | 105.633 |
| Total Expenses - EUR | 12.944 | 26.030 | 35.700 | 43.001 | 58.089 | 55.252 | 65.084 | 80.550 | 77.829 | 86.556 |
| Gross Profit/Loss - EUR | 9.928 | 19.086 | 18.536 | 24.447 | 14.848 | 25.811 | 33.333 | 16.253 | 31.200 | 19.077 |
| Net Profit/Loss - EUR | 9.242 | 18.635 | 17.996 | 23.772 | 14.119 | 25.056 | 32.577 | 15.381 | 30.197 | 16.383 |
| Employees | 2 | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Nico David Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.038 | 13.221 | 9.656 | 41.848 | 57.491 | 48.585 | 41.035 | 43.054 | 47.538 | 44.620 |
| Current Assets | 9.676 | 20.549 | 16.651 | 14.537 | 23.173 | 50.534 | 77.249 | 32.881 | 48.131 | 62.067 |
| Inventories | 1.205 | 0 | 0 | 0 | 0 | 451 | 1.578 | 0 | 0 | 1.700 |
| Receivables | 3.739 | 9.517 | 5.830 | 9.025 | 6.560 | 2.676 | 10.166 | 17.554 | 18.781 | 32.803 |
| Cash | 4.732 | 11.032 | 10.821 | 5.512 | 16.613 | 47.407 | 65.505 | 15.326 | 29.350 | 27.564 |
| Shareholders Funds | 9.287 | 27.828 | 18.048 | 41.489 | 54.804 | 78.822 | 109.650 | 66.258 | 85.268 | 85.878 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.962 | 5.943 | 8.258 | 14.896 | 25.859 | 20.297 | 8.633 | 9.677 | 10.401 | 20.809 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nico David Med S.r.l.